PROTAC FLT-3 degrader 1
98%
- Product Code: 106390
CAS:
2230826-81-8
| Molecular Weight: | 1020.23 g./mol | Molecular Formula: | C₅₂H₆₁N₉O₉S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in cancer research, this compound targets and degrades FLT-3, a protein often mutated in acute myeloid leukemia (AML). By leveraging the PROTAC (Proteolysis Targeting Chimera) technology, it facilitates the breakdown of FLT-3, reducing its levels in cancer cells. This approach helps in inhibiting the growth and survival of leukemia cells, offering a potential therapeutic strategy for FLT-3-driven cancers. It is particularly studied for its ability to overcome resistance to traditional FLT-3 inhibitors, making it a promising candidate for advanced AML treatment.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿77,400.00 |
+
-
|
PROTAC FLT-3 degrader 1
Used primarily in cancer research, this compound targets and degrades FLT-3, a protein often mutated in acute myeloid leukemia (AML). By leveraging the PROTAC (Proteolysis Targeting Chimera) technology, it facilitates the breakdown of FLT-3, reducing its levels in cancer cells. This approach helps in inhibiting the growth and survival of leukemia cells, offering a potential therapeutic strategy for FLT-3-driven cancers. It is particularly studied for its ability to overcome resistance to traditional FLT-3 inhibitors, making it a promising candidate for advanced AML treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :